BlackRock, Inc. 13D and 13G filings for Beam Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 7,499,930 7.500% | -248,347 (-3.21%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 7,748,277 9.400% | 0 (Unchanged) | Filing |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 7,748,277 9.400% | 1,086,234 (+16.30%) | Filing |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 6,662,043 8.200% | 1,423,763 (+27.18%) | Filing |
| 2023-02-02 4:05 pm Purchase | 2022-12-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 5,238,280 7.400% | 1,175,486 (+28.93%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 4,062,794 6.000% | 970,983 (+31.40%) | Filing |
| 2021-04-09 6:02 pm Sale | 2021-03-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 3,091,811 5.000% | -67,699 (-2.14%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 3,159,510 5.500% | 3,159,510 (New Position) | Filing |